| 中文名稱:IDO1-IN-7 | 英文名稱:IDO1-IN-7 |
| CAS:2351199-98-7 | 品牌: TargetMol |
| 產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 產(chǎn)品類別: 抑制劑 | |
| 貨號: T39888 |
| 名稱 | IDO1-IN-7 |
| 描述 | IDO1-IN-7, a potent and selective indoleamine-2,3-dioxygenase-1 (IDO1) inhibitor, exhibits high potency with an IC 50 of 6.1 nM in the cellular assay (SKOV3). Apart from its inhibitory properties, IDO1-IN-7 also demonstrates immunomodulatory effects, contributing to its potential applications in cancer research. |
| 體外活性 | IDO1-IN-7 exhibits moderate potency in a human whole blood assay with an IC 50 of 330 nM[1]. IDO1-IN-7 shows a favorable profile such as good metabolic stability and acceptable off-target selectivity[1]. IDO1-IN-7 shows a high selectivity for IDO1 over tryptophan 2,3-dioxygenase (TDO) (IC 50 =14,000 nM)[1]. |
| 體內(nèi)活性 | IDO1-IN-7 (10 mg/kg; p.o.) shows C max =10.0 μM, AUC 0-8 h =27.1 μM*h, t 1/2 =1.4 h in mouse[1]. Animal Model: Mouse[1]Dosage: 10 mg/kg (Pharmacokinetic Analysis) Administration: Oral administration Result: C max (10.0 μM), AUC 0-8 h (27.1 μM*h), t 1/2 (1.4 h) |
| 存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 關(guān)鍵字 | IDO-1-IN-7 | IDO1IN7 | IDO1 IN 7 |
| 相關(guān)產(chǎn)品 | IDO-IN-12 | Indoximod | Palmatine | TDO-IN-1 | GNF-PF-3777 | Necrostatin-1 | IDO-IN-7 | IDO1-IN-28 | Epacadostat | 3-TYP | Palmatine chloride | β-Lapachone |
| 成立日期 | 2013-04-18 (14年) | 注冊資本 | 589.8595萬人民幣 |
| 員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
| 主營行業(yè) | 中間體,天然產(chǎn)物,生物化工,化學(xué)試劑,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
|---|---|---|---|---|
| 詢價 |
VIP7年
|
上海澤葉生物科技有限公司
|
2026-06-09 | |
| 詢價 |
VIP4年
|
武漢佰樂博生物技術(shù)有限公司
|
2026-06-09 | |
| ¥1950 |
VIP4年
|
上海滬震實業(yè)有限公司
|
2026-06-09 |